EGFR and lung carcinoma: Moreover, some other pathways were also identified in the present study, such as the MAPK, p53, Wnt, JAK-STAT, ERBB, NF-κB, and ubiquitin mediated proteolysis signaling pathways, which altered during the process of drug-resistance of murine lung cancer isografts in vivo.